Cntx ticker
WebApr 6, 2024 · The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. Contact ... WebApr 4, 2024 · Ticker Symbol: CNTX: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $5.00: CIK Code: 0001842952: CUSIP …
Cntx ticker
Did you know?
WebApr 10, 2024 · CNTX Stock: The Breast Cancer Clinical Trial Data That Has Context Therapeutics Soaring Today. Context Therapeutics (CNTX) stock is rising higher on … WebCNTX insider trading, corporate lobbying, Congressional trading, social media sentiment, stock price movement, and more CNTX - Context Therapeutics Inc. Common Stock …
WebContext Therapeutics Inc. Common Stock (CNTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. WebContext Therapeutics (CNTX) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ... Stock Ticker Symbol Market Type; Context Therapeutics Inc: CNTX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.0137-2.3%: 0.582: 16:59:08: Open Price …
WebBreakout Boards Most Read Most Posted Most Followed Members Active Boards New Boards Site Stats My Stocks Activity Ticker Buzz Cloud. Mailbox ... Find Boards containing: CNTX. Ticker Board Posts Status Last Post Category; CNTX: Context Therapeutics Inc: 96: 1 … WebView the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebTicker: CNTX; CUSIP Number: 21077p108; Tip: Access positions for across all investors. Analyze quarterly positions in Context Therapeutics with up to 7 years of data, all consolidated into one spreadsheet . Download as csv Download as Excel. Top investors of Context Therapeutics stock.
WebJan 16, 2024 · Shares of Context Therapeutics Inc. are traded on the stock exchange under the ticker CNTX and belong to the "Healthcare" sector. The head office is currently located at: 3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, US. The market capitalization of Context Therapeutics is $30 654 900. chapter 14 class 8 scienceWebCurrent and historical p/e ratio for Context Therapeutics (CNTX) from 2024 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. chapter 14 cosmetology miladyWebFind the latest Centogene N.V. (CNTG) stock quote, history, news and other vital information to help you with your stock trading and investing. chapter 14 econWebGet the latest Context Therapeutics Inc (CNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … chapter 14 class 6 science pdfWebJan 12, 2024 · In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Context Therapeutics (CNTX - Research Report), with a price target of … chapter 14 dickey physicsWebMar 23, 2024 · Ticker: CNTX CIK: 1842952 Form Type: 10-K Annual Report Accession Number: 0001842952-22-000029 Submitted to the SEC: Wed Mar 23 2024 4:17:57 PM EST Accepted by the SEC: Wed Mar 23 2024 Period: Friday, December 31, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote chapter 14 economicsWebJan 12, 2024 · In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Context Therapeutics (CNTX - Research Report), with a price target of $6.00. The company's shares closed yesterday at $1.38.According to TipRanks, Bodnar is an analyst with an average return of -13.8% and a 24.07% success rate. chapter 14. economic and social policy